Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-005539
Filing Date
2020-03-05
Accepted
2020-03-05 19:18:07
Documents
1
Period of Report
2020-03-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3889
  Complete submission text file 0001213900-20-005539.txt   5486
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Goodman Tony (Reporting) CIK: 0001717971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38323 | Film No.: 20692195